Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects

Eur J Immunol. 1997 May;27(5):1131-9. doi: 10.1002/eji.1830270513.

Abstract

The current study was carried out to elucidate the immunoregulatory changes induced by venom immunotherapy (VIT) in bee or wasp allergic subjects. All subjects included in this study had a history of severe systemic allergic reactions to stings of the respective insect as well as positive skin tests with the respective venom or venom-specific IgE in the sera. Parameters assessed in peripheral blood mononuclear cells (PBMC) before and after initiation of VIT (rush therapy reaching a maintenance dose of 100 micrograms venom injected subcutaneously within 1 week) were expression of CD3, CD4, CD8, CD45RA, CD45RO, interleukin (IL)-2 receptor (R) alpha, IL-4R, IL-12R, Fc epsilon RII, CD40, and CD40 ligand (CD40L), cells producing interferon (IFN)-gamma and IL-10 after stimulation with phorbol 12-myristate 13-acetate + ionomycin in the presence of monensin measured by flow cytometry; secretion of IFN-gamma, IL-4, and IL-10 measured by ELISA (IFN-gamma and IL-10 were additionally measured by PCR), and proliferation after stimulation with the respective venom. Significant decreases were observed after VIT for proliferative response to venom and venom + IL-4, IL-4 secretion, Fc epsilon RII, CD40, and CD40L expression. Significant increases were observed after VIT for IFN-gamma concerning the amount secreted and the number of producing cells, and IL-10, IL-10 was mainly produced by CD4+ cells that were negative for IFN-gamma, but some double-positive (IL-10 and IFN-gamma) cells were always detected. Addition of blocking anti-IL-10 antibodies, but not isotype control antibodies, prevented down-regulation of proliferation (but not IL-4 secretion) and further enhanced IFN-gamma secretion after VIT. These data indicate that in insect venom allergic subjects, VIT not only induces a rapid shift in cytokine expression from Th2 to Th1 cytokines, but also leads to induction of the immunosuppressive cytokine IL-10, which may be important for the limitation of potentially harmful allergen-specific Th1 responses. The described changes in cytokine expression may be responsible for subsequent increases in allergen-specific IgG and decreases in IgE production, as well as suppressive activity observed in earlier studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens / pharmacology*
  • Allergens / therapeutic use
  • Antibodies, Monoclonal / pharmacology
  • Antigens, CD / biosynthesis
  • Antigens, Surface / biosynthesis*
  • Bee Venoms / immunology
  • Bee Venoms / pharmacology*
  • Bee Venoms / therapeutic use
  • CD40 Antigens / biosynthesis
  • CD40 Ligand
  • Desensitization, Immunologic / methods
  • Down-Regulation / immunology
  • Humans
  • Insect Bites and Stings / immunology
  • Insect Bites and Stings / therapy*
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / immunology
  • Interleukin-10 / biosynthesis*
  • Interleukin-10 / genetics
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / immunology
  • Ligands
  • Lymphocyte Activation / drug effects
  • Lymphocyte Count
  • Membrane Glycoproteins / biosynthesis
  • RNA, Messenger / biosynthesis
  • Receptors, IgE / biosynthesis
  • Receptors, Interleukin / biosynthesis
  • Receptors, Interleukin-4
  • T-Lymphocyte Subsets / cytology
  • Th1 Cells / drug effects
  • Th1 Cells / immunology*
  • Th2 Cells / drug effects
  • Th2 Cells / immunology*
  • Time Factors
  • Wasp Venoms / immunology
  • Wasp Venoms / pharmacology*
  • Wasp Venoms / therapeutic use

Substances

  • Allergens
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Surface
  • Bee Venoms
  • CD40 Antigens
  • Ligands
  • Membrane Glycoproteins
  • RNA, Messenger
  • Receptors, IgE
  • Receptors, Interleukin
  • Receptors, Interleukin-4
  • Wasp Venoms
  • Interleukin-10
  • CD40 Ligand
  • Interleukin-4
  • Interferon-gamma